1 – 10 of 10
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Electrocardiographic scores of severity and acuteness of myocardial ischemia predict myocardial salvage in patients with anterior ST-segment elevation myocardial infarction
(
- Contribution to journal › Article
-
Mark
The significance of ST-elevation in aVL in anterolateral myocardial infarction : An assessment by cardiac magnetic resonance imaging
(
- Contribution to journal › Article
-
Mark
Correlation of anteroseptal ST elevation with myocardial infarction territories through cardiovascular magnetic resonance imaging
(
- Contribution to journal › Article
-
Mark
Appropriateness of anteroseptal myocardial infarction nomenclature evaluated by late gadolinium enhancement cardiovascular magnetic resonance imaging
(
- Contribution to journal › Article
- 2017
-
Mark
Time-resolved tracking of the atrioventricular plane displacement in Cardiovascular Magnetic Resonance (CMR) images
(
- Contribution to journal › Article
- 2016
-
Mark
Sample Size in Clinical Cardioprotection Trials Using Myocardial Salvage Index, Infarct Size, or Biochemical Markers as Endpoint.
(
- Contribution to journal › Article
- 2015
-
Mark
Design of clinical cardioprotection trials using CMR : Impact of myocardial salvage index and a narrow inclusion window on sample size
(
- Contribution to journal › Published meeting abstract
-
Mark
Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results.
(
- Contribution to journal › Article
-
Mark
Rationale and design of the Cyclosporine to ImpRove Clinical oUtcome in ST-elevation myocardial infarction patients (the CIRCUS trial)
(
- Contribution to journal › Article
- 2012
-
Mark
Rationale and Design of the 'MITOCARE' Study: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of TRO40303 for the Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction
(
- Contribution to journal › Article